Aeovian Pharmaceuticals

About:

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

Website: https://www.aeovian.com/

Top Investors: Sofinnova Investments, Evotec, venBio Partners, b2venture, Apollo Health Ventures

Description:

Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Aeovian Pharmaceuticals was founded in 2012.

Total Funding Amount:

$87M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2012-01-01

Founders:

James Peyer, Stelios Tzannis

Number of Employees:

1-10

Last Funding Date:

2024-03-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai